Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin vs Starch in Renal Transplant Surgery
NCT03306914Completed
- Sponsor
- Cairo University
- Start
- Oct 2017
- Primary completion
- Feb 2019
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of hetastarch in end stage renal disease (ESRD) (2 arms), sponsored by Cairo University. Primary endpoint: Occurrence of complications at 7 days. Started Oct 2017; status: completed.
02
Drugs
hetastarch
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT03306914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03306914.